In vivo efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated falciparum malaria in children: a multisite, open-label, two-cohort, clinical trial in Mozambique
Malar. j. (Online); 13 (309), 2014
Background: Mozambique adopted artemisinin-based combination therapy (ACT) for the treatment of uncomplicated Plasmodium falciparum malaria in the year 2006, and since 2009 artemether-lumefantrine (AL) and artesunateamodiaquine (ASAQ) have been proposed as alternative first-line treatments. A multicentre...
Amodiaquina/uso terapêutico, Antimaláricos/efeitos adversos, Antimaláricos/uso terapêutico, Combinação Arteméter e Lumefantrina, Artemisininas/efeitos adversos, Artemisininas/uso terapêutico, Combinação de Medicamentos, Etanolaminas/efeitos adversos, Etanolaminas/uso terapêutico, Artesunato/uso terapêutico, Fluorenos/uso terapêutico, Malária Falciparum/tratamento farmacológico, Malária Falciparum/epidemiologia, Combinação Arteméter e Lumefantrina/uso terapêutico, Moçambique/epidemiologia